Published in Am J Pathol on April 01, 2000
Stem cell-derived endochondral cartilage stimulates bone healing by tissue transformation. J Bone Miner Res (2014) 1.19
Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development. Am J Pathol (2001) 0.98
The multifaceted role of the vasculature in endochondral fracture repair. Front Endocrinol (Lausanne) (2015) 0.85
Actin and Vimentin proteins with N-terminal deletion detected in tumor-bearing rat livers induced by intraportal-vein injection of Ha-ras-transfected rat liver cells. Int J Cancer (2009) 0.80
Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations. Am J Pathol (2002) 0.78
Intracranial mesenchymal chondrosarcoma with osteoid formation: report of a pediatric case. Childs Nerv Syst (2003) 0.77
Mesenchymal chondrosarcoma of the cervical spine: A case report. Australas Med J (2011) 0.76
Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells. Tissue Eng Part A (2015) 0.75
Chondroma of epithelial cell origin. Am J Pathol (2003) 0.75
Cartilage contains mixed fibrils of collagen types II, IX, and XI. J Cell Biol (1989) 2.68
Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen. J Immunol Methods (1976) 2.28
Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol (1999) 2.17
Chondrocyte differentiation. Int Rev Cytol (1995) 2.15
Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. J Cell Biol (1988) 2.05
Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer (1986) 1.96
Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide. J Cell Biol (1991) 1.66
Mesenchymal chondrosarcoma--observations on 30 new cases. Cancer (1971) 1.62
Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer (1983) 1.49
Mesenchymal chondrosarcoma of bone and soft tissues. Cancer (1983) 1.48
Chondrons from articular cartilage: I. Immunolocalization of type VI collagen in the pericellular capsule of isolated canine tibial chondrons. J Cell Sci (1988) 1.39
Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J (1992) 1.38
S-100 protein in human chondrocytes. Nature (1982) 1.35
Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol (1995) 1.35
Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development. Dev Dyn (1994) 1.33
Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol (1996) 1.30
End labeling studies of fragmented DNA in the avian growth plate: evidence of apoptosis in terminally differentiated chondrocytes. J Bone Miner Res (1995) 1.28
Hypertrophic chondrocytes undergo further differentiation in culture. J Cell Biol (1992) 1.25
Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 1.23
Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem (1997) 1.20
Meningeal mesenchymal chondrosarcoma: report of 8 cases with review of the literature. Cancer (1978) 1.19
Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res (1991) 1.19
Extraskeletal mesenchymal chondrosarcoma. Arch Pathol (1973) 1.16
Collagen types IX and X in the developing chick tibiotarsus: analyses of mRNAs and proteins. Development (1991) 1.15
Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1986) 1.12
Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer (1996) 1.03
In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Dev Biol (1991) 1.01
Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum (1998) 0.98
Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J Pathol (1996) 0.95
Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology (1997) 0.95
Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol (1997) 0.95
Mesenchymal chondrosarcoma in the young. Virchows Arch A Pathol Anat Histopathol (1983) 0.94
Simultaneous localization of proteoglycan by light and electron microscopy using toluidine blue O. A study of epiphyseal cartilage. J Histochem Cytochem (1976) 0.92
S-100 protein in tumors of cartilage and bone. An immunohistochemical study. Cancer (1983) 0.91
Histochemical characterization of mucosubstances in bone and soft tissue-tumors. Cancer (1975) 0.89
An ultrastructural study of extraskeletal mesenchymal chondrosarcoma. Acta Pathol Jpn (1984) 0.88
Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol (1996) 0.88
Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage. Cancer (1988) 0.88
Mesenchymal chondrosarcoma. A study of the ultrastructure. Cancer (1973) 0.86
A comparative ultrastructural study of mesenchymal chondrosarcoma and myxoid chondrosarcoma. Cancer (1974) 0.86
Ultrastructure of cartilaginous tumors and S-100 protein in the tumors. With reference to the histogenesis of chondroblastoma, chondromyxoid fibroma and mesenchymal chondrosarcoma. Acta Pathol Jpn (1984) 0.86
Chondrocytic cell differentiation in clear cell chondrosarcoma. Hum Pathol (1996) 0.85
Ultrastructural study of conventional chondrosarcomas and myxoid- and mesenchymal-chondrosarcomas. Virchows Arch A Pathol Anat Histol (1982) 0.84
Mesenchymal chondrosarcoma. A cytogenetic, immunohistochemical and ultrastructural study. Cancer Genet Cytogenet (1995) 0.82
Mesenchymal chondrosarcoma. An immunohistochemical study. Arch Pathol Lab Med (1990) 0.81
Primary mesenchymal chondrosarcoma of the lung. A case report with immunohistochemical and ultrastructural studies. Acta Pathol Jpn (1992) 0.81
Primary meningeal mesenchymal chondrosarcoma. Arch Pathol Lab Med (1979) 0.81
Establishment of bone morphogenetic protein 2 responsive chondrogenic cell line. J Bone Miner Res (1996) 0.80
Polyhistioma: a malignant tumor of bone and extraskeletal tissues. Cancer (1977) 0.78
Intracranial mesenchymal chondrosarcoma. Acta Neuropathol (1973) 0.78
A case of mesenchymal chondrosarcoma of the orbit. Acta Ophthalmol (Copenh) (1980) 0.76
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Defective B cell development and function in Btk-deficient mice. Immunity (1995) 4.20
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
Role of SUMO-1-modified PML in nuclear body formation. Blood (2000) 4.05
Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med (1996) 3.86
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol (2001) 3.43
Cytochromes c1 and b2 are sorted to the intermembrane space of yeast mitochondria by a stop-transfer mechanism. Cell (1992) 3.42
Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J (1994) 3.27
Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res (1992) 2.89
Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer (1992) 2.84
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
Osteosarcoma of the jaw. Cancer (1983) 2.46
Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol (1994) 2.27
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Cytochrome c oxidase assembly in primates is sensitive to small evolutionary variations in amino acid sequence. Mol Biol Evol (2000) 2.19
Chondrosarcoma arising in osteochondroma. Cancer (1982) 2.17
Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol (1999) 2.17
PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci (2003) 2.15
The human Rad52 protein exists as a heptameric ring. Curr Biol (2000) 2.09
Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J Exp Med (1997) 2.06
Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex. Mol Biol Cell (1995) 2.04
Complete DNA sequence of yeast chromosome II. EMBO J (1994) 1.97
Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer (1986) 1.96
Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer (1995) 1.94
Malignancies in fibrous dysplasia. Cancer (1994) 1.91
Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol (2001) 1.90
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest (1988) 1.89
Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol (1998) 1.89
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res (1999) 1.82
Bizarre parosteal osteochondromatous proliferation of bone (Nora's lesion). Am J Surg Pathol (1993) 1.82
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil (2008) 1.80
Metastases from histologically benign giant-cell tumor of bone. J Bone Joint Surg Am (1984) 1.78
Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol (1997) 1.78
Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases. AJR Am J Roentgenol (1992) 1.77
Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br (1998) 1.76
Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem (1990) 1.75
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Laufband therapy based on 'rules of spinal locomotion' is effective in spinal cord injured persons. Eur J Neurosci (1995) 1.72
Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop Relat Res (1989) 1.70
Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study. Am J Clin Pathol (1984) 1.70
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
Natural variation in the response of Caenorhabditis elegans towards Bacillus thuringiensis. Parasitology (2004) 1.70
Ewing's sarcoma of bone. Experience with 140 patients. Cancer (1986) 1.70
Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun (1998) 1.67
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
Malignant lymphoma of bone. Cancer (1986) 1.66
Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries. Paraplegia (1992) 1.66
Pigmented villonodular synovitis of the spine: a clinical, radiological, and morphological study of 12 cases. J Neurosurg (1996) 1.64
Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem (2000) 1.63
Effects of staff training on the care of mechanically ventilated patients: a prospective cohort study. Br J Anaesth (2009) 1.63
Giant cell tumor of the skull. Cancer (1992) 1.62
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Primary chondrosarcoma of long bones and limb girdles. Cancer (1998) 1.61
Giant-cell tumours of the spine. J Bone Joint Surg Br (1993) 1.60
Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest (1990) 1.60
Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr (1995) 1.59
Osteogenic melanoma. A rare variant of malignant melanoma. Am J Surg Pathol (1993) 1.59
Low-grade intraosseous osteosarcoma. Cancer (1990) 1.59
Desmoplastic fibroma of bone. Cancer (1991) 1.58
Beam hardening artefacts occur in dental implant scans with the NewTom cone beam CT but not with the dental 4-row multidetector CT. Dentomaxillofac Radiol (2007) 1.58
Adamantinoma of long bones. A clinicopathologic study of 85 cases. Cancer (1989) 1.55
Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem (1991) 1.55
Phosducin is a protein kinase A-regulated G-protein regulator. Nature (1992) 1.55
Internalin B is essential for adhesion and mediates the invasion of Listeria monocytogenes into human endothelial cells. Mol Microbiol (1998) 1.54
Structure and sequence of the chicken type II procollagen gene. Characterization of the region encoding the carboxyl-terminal telopeptide and propeptide. J Biol Chem (1984) 1.54
Probing the molecular environment of membrane proteins in vivo. Mol Biol Cell (1999) 1.53
Chondrosarcoma of the jaw and facial bones. Cancer (1995) 1.53
Epithelioid hemangioendothelioma of bone. Am J Surg Pathol (1996) 1.52
Recruitment of spinal motor pools during voluntary movements versus stepping after human spinal cord injury. J Neurotrauma (2002) 1.51
Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am (2001) 1.48
Malignant fibrous histiocytoma of bone. A clinicopathologic study of 81 patients. Cancer (1997) 1.47
Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer (2011) 1.46
Chondrosarcomas of the synovium. Cancer (1991) 1.45
Chondrosarcoma of the chest wall: factors affecting survival. Ann Thorac Surg (1985) 1.45
Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr Biol (2000) 1.45
Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation. Bone Marrow Transplant (1998) 1.43
Fibrocartilagenous mesenchymoma of bone. Am J Surg Pathol (1993) 1.42
Treatment of aneurysmal bone cysts of the pelvis and sacrum. J Bone Joint Surg Am (2001) 1.42
Malignant lesions arising in chronic osteomyelitis. Clin Orthop Relat Res (1999) 1.42
Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg Am (1979) 1.41
Osseous Hodgkin disease. Cancer (1999) 1.41
Human herpesvirus 6 DNA in exanthematous skin in BMT patient. Lancet (1994) 1.40
Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2000) 1.40
Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis (2013) 1.40
MUC1: the polymorphic appearance of a human mucin. Glycobiology (2000) 1.39
Brain representation of active and passive movements. Neuroimage (1996) 1.36
Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies. Mol Cell Biol (2000) 1.36
Characterization of KIF1C, a new kinesin-like protein involved in vesicle transport from the Golgi apparatus to the endoplasmic reticulum. J Biol Chem (1998) 1.35
Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene (2001) 1.35
Hemangioma, hemangiopericytoma, and hemangioendothelioma (angiosarcoma) of bone. Cancer (1971) 1.34